Clinical study on Yihong Kangnaoshuan capsule in treating lacunar infarction pure motor hemiparesis.
- Author:
Ji-dong ZHOU
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Capsules;
Cerebral Infarction;
drug therapy;
Drugs, Chinese Herbal;
therapeutic use;
Female;
Humans;
Male;
Middle Aged;
Paresis;
drug therapy
- From:
China Journal of Chinese Materia Medica
2015;40(11):2235-2238
- CountryChina
- Language:Chinese
-
Abstract:
With the treatment of lacunar cerebral infarction with pure motor hemiparesis (PMH) attach importance to the treatment effect, application benefit of Yihong Kangnaoshuan capsule in the treatment of further effect. Treatment of PMH is mainly depending on the thorough discussion on the cause, to determine the clinical value of treatment based on the principle of. Through the research of Zhejiang People's Hospital of Fenghua from 2013 March to 2014 September 178 cases of pure motor hemiparesis were the benefit of Yihong Kangnaoshuan capsule and vedrin capsule treatment, compared the indexes of efficacy after treatment and blood rheology. Finally found the benefits of Yihong Kangnaoshuan capsule in the application process with high safety, efficacy and greater proportion. And in favor of blood lipid and blood rheology indicators of stability, the repair of neurological function is more. Therefore, clinicians should be applied benefit of red brain thrombus capsule in the treatment of PMH. But the overall difference between drugs is need to further comparison, in order to ensure clinical curative effect.
